Deplin

Quick links to important sections

Deplin

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deplin

Quick Facts

Property Description
Active ingredient L-methylfolate (Levomefolic acid)
Form Capsule, Tablet
Pharmacological class Folate Analog, Tri-monoamine Modulator (TMM)
Type/Classification Prescription Medical Food
Origin Biologically active metabolite of Vitamin B9

Deplin: A Prescription Medical Food for Targeted Nutritional Support

Deplin is an oral preparation uniquely identified as a Prescription Medical Food in the United States. This specific categorization means the product is intended for the clinical dietary management of established nutritional requirements linked to a specific condition, necessitating its use under the direction of a healthcare professional. Its function is distinct from that of general dietary supplements or traditional pharmaceuticals, as its primary purpose is to address specific metabolic needs rather than directly modifying a disease state. L-methylfolate is the active and final metabolite of folate necessary for the central nervous system.

What is the Active Ingredient in Deplin?

The single active component in this preparation is L-methylfolate calcium (INN: Levomefolic acid), delivered in a capsule or tablet form. This compound is the biologically active metabolite of Vitamin B9 (folate), making its origin derived rather than synthetic. Chemically, L-methylfolate is classified as a Folate Analog. Crucially, this compound is considered bioavailable because it is already in the form the body can directly utilize, bypassing enzymatic conversion steps often impaired in genetically predisposed individuals.

Why is L-methylfolate Necessary for Neurotransmitters?

L-methylfolate is a crucial methyl group donor that is essential for the fundamental synthesis of brain chemical messengers, acting as a Tri-monoamine Modulator (TMM). Specifically, its role is to regulate the production of the monoamine neurotransmitters: serotonin, dopamine, and norepinephrine. Unlike its inactive precursors, L-methylfolate is the only form of folate capable of efficiently crossing the blood-brain barrier to participate in central nervous system metabolism. This unique property ensures the necessary substrate is available to support balanced neurotransmitter synthesis and overall neurological function.

Regulatory References

  1. Label: L-METHYLFOLATE CALCIUM - DailyMed
  2. L-methylfolate: a vitamin for your monoamines

What side effects are possible with Deplin?

Possible Side Effects and Safety Information

The following safety information is derived from official governmental regulatory documents for Deplin (L-methylfolate).


Documented Adverse Reactions

The most frequently reported side effects affect the nervous and gastrointestinal systems. These reactions are typically categorized as Frequency Not Defined in regulatory labeling, meaning their exact occurrence rate is not established through controlled trials.

System Reported Side Effects
Psychiatric/Nervous System Altered sleep patterns, difficulty concentrating, irritability, excitement, overactivity, confusion.
Gastrointestinal Nausea, flatulence, abdominal distention, anorexia.
Other Bitter or bad taste.

Serious Safety Warnings and Restrictions

1. Risk of Masking Pernicious Anemia: Deplin is officially restricted from being used as the sole treatment (monotherapy) for megaloblastic anemias caused by Vitamin B12 deficiency. Doses greater than 0.1 mg/day may reverse the blood-related symptoms of pernicious anemia while allowing irreversible neurological damage to continue to progress.

2. Contraindications: Use is strictly contraindicated in patients with a known history of hypersensitivity or allergic reactions to L-methylfolate or any component of the product.

3. Population-Specific Safety:

  • Pregnancy: The product is generally considered acceptable, classified as FDA Pregnancy Category A (controlled human studies show no evidence of fetal risk).
  • Renal/Hepatic Impairment: The daily dose should not exceed 40 mg in patients with moderate-to-severe kidney or liver impairment.

4. Duration-Related Note: Prolonged therapy may be associated with a decrease in Vitamin B12 serum levels.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for L-methylfolate (Deplin) overdose reflects a low acute toxicity risk. Based on government-authorized prescribing information, a significant overdose is not considered likely to cause life-threatening symptoms. This minimal risk profile is consistent with the product’s regulatory classification. Regulatory documentation does not typically describe a specific, comprehensive cluster of acute, severe clinical manifestations or physiological abnormalities in the event of an overdose. Furthermore, no specific antidote is documented in the official prescribing information for L-methylfolate.

Emergency Actions Mandated by Regulation

Despite the established low acute toxicity profile, regulatory authorities mandate specific, immediate actions for all suspected accidental overdoses. These instructions are mandatory and require immediate external guidance as per the official label text.

Action Required Official Regulatory Instruction
Immediate Assistance Seek professional assistance immediately upon suspected accidental overdose.
Urgent Contact Contact a Poison Control Center immediately for guidance following suspected ingestion.

The regulatory text does not detail specific procedural supportive management measures, such as gastric lavage or mandatory hospital monitoring requirements. The official documentation's primary focus is solely on the immediate requirement to seek professional assistance and contact a Poison Control Center for all potential overdose scenarios, ensuring timely professional evaluation.

Therapeutic Uses of Deplin

What Deplin Treats: Main Uses and Benefits

Deplin is commonly used as an adjunctive therapy for adults with Major Depressive Disorder (MDD), particularly when patients have experienced an inadequate response to standard antidepressant treatment. This approach is relevant for patients struggling with persistent, residual symptoms that interfere with daily functioning, such as ongoing low mood, fatigue, and impaired concentration. Using the active form of folate directly in this clinical setting supports general well-being and contributes to easing the overall symptom load.

The medication is relevant in clinical settings marked by temporary physiological imbalance, specifically where depressive symptoms may be associated with the patient having specific nutritional requirements related to the utilization of folate. This supportive relief assists with maintaining functional stability by providing the active nutrient, and may help the central nervous system receive the nutrient appropriate for balanced function. The main indications are MDD with inadequate response, residual depressive symptoms, and nutritional requirements associated with schizophrenia.


Quick Fact: Relief for Residual Symptoms
Primary Context Augmentation of standard antidepressant therapy.
Symptom Focus Lingering fatigue, anhedonia (loss of pleasure), and poor concentration.
Patient Benefit Contributes to improved comfort during symptomatic periods, easing the overall symptom load.

Eligibility and Restrictions for Use

Who Can and Cannot Use Deplin?


Deplin (L-methylfolate) is regulated as a prescription medical food intended for the clinical dietary management of specific metabolic imbalances. Its use is therefore limited to patients under the supervision of a licensed healthcare provider.

Populations that Must Not Use Deplin

  • Contraindicated Populations: Individuals with a documented hypersensitivity or previous intolerance to L-methylfolate or any other ingredient in the product must not use Deplin.

Populations with Use Restrictions

  • Vitamin B12 Deficiency: Deplin should not be administered as monotherapy to patients with pernicious anemia or other megaloblastic anemias resulting from a confirmed Vitamin B12 deficiency. Using folate alone in this context may correct the hematological symptoms while allowing potentially irreversible neurological damage to advance.
  • Age Restrictions: Safety and effectiveness for use in children and adolescents have not been established.

Pregnancy and Physiological States

  • Pregnancy and Lactation: L-methylfolate is generally considered acceptable during pregnancy (Pregnancy Category A). It is distributed into breast milk in amounts adequate to meet the infant's daily requirements, and supplemental intake during these periods is generally regarded as beneficial.
  • Organ Impairment: Dose adjustments are not necessary for patients with moderate-to-severe renal or hepatic impairment.

What should I know about interactions with other medicines?

Deplin (L-methylfolate) is a medical food that provides the biologically active form of folate. While it generally has a low risk for significant interactions, it is essential to discuss all prescription and non-prescription medications, vitamins, and herbal products with a healthcare professional.

Medications that May Interact with Deplin

Certain medications may affect the body's folate levels, potentially necessitating an adjustment in Deplin dosage, or Deplin may affect the plasma levels of other drugs. Consult your healthcare provider if you are taking any of the following:

  • Anticonvulsants/Seizure Medicines: Including phenytoin, phenobarbital, primidone, carbamazepine, lamotrigine, and valproic acid. L-methylfolate may reduce the plasma levels of these drugs.
  • Chemotherapy and Anti-malarial Drugs: Methotrexate, pyrimethamine, and trimethoprim may interfere with folate metabolism.
  • Other Agents: Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, certain oral contraceptives, metformin (for diabetes), and warfarin (a blood thinner) are known to interact with folate levels and function.
Interaction Type Examples of Affected Drugs
Reduced Plasma Levels Phenytoin, Valproic Acid, Pyrimethamine
Interference with Folate Methotrexate, Trimethoprim, NSAIDs, Oral Contraceptives

Deplin is used as an adjunctive therapy and may enhance the effects of antidepressant medications when used concomitantly. However, using Deplin in patients with undiagnosed bipolar disorder carries a risk of activating a manic or hypomanic episode, a consideration common when augmenting antidepressant treatment.

Mechanism of Action

L-methylfolate (Levomefolic acid) acts exclusively as the biologically active form of Folate, supplying a vital chemical component directly to the central nervous system (CNS) via the Proton-Coupled Folate Transporter (PCFT) to regulate key metabolic pathways.

Driving One-Carbon Metabolism and Methylation

This mechanism centers on L-methylfolate's role as a direct methyl group donor that drives the One-Carbon Metabolism cycle within the brain. By interacting with the Methionine Synthase enzyme, it facilitates the transformation of Homocysteine back into Methionine. This action replenishes the pool of S-adenosylmethionine (SAMe), the universal methyl donor, which supports a key physiological reaction for subsequent methylation reactions that regulate neuronal cell function.

Modulating Neurotransmitter Synthesis

The continuous support of the methylation cycle is essential for maintaining the biochemical environment necessary for synthesizing monoamine neurotransmitters. The downstream effect of L-methylfolate's action is the enhanced availability of the cofactors required by Tryptophan and Tyrosine Hydroxylase, the rate-limiting enzymes for the production of Serotonin, Dopamine, and Norepinephrine. This supports the modulation of these key neurochemical pools in the CNS, acting as a Tri-monoamine Modulator (TMM) to modulate neuronal signaling.

Dosage and Administration Information

Official Administration Guidelines

Element Instruction
Route of Administration Oral (by mouth)
Dosing Schedule The usual adult daily dose ranges from 7.5 mg to 15 mg.
Timing in Relation to Meals May be taken with or without food.
Preparation Requirements The capsule or tablet is intended to be swallowed whole.

Procedural Structure and Constraints

Deplin is an oral preparation available in 7.5 mg and 15 mg strengths. It is administered once daily (qDay) as part of a continuous plan. The product is intended for use only under the supervision of a physician due to its designation as a Prescription Medical Food.

There are specific constraints related to proper administration. Folate therapy alone is inadequate for the management of a Vitamin B12 deficiency, and the product is not intended for use as monotherapy in cases of pernicious or other megaloblastic anemias when B12 deficiency is known to be present.

Population-Specific Usage:

The product's safety and efficacy have not been established for use in patients under 18 years of age. For older adults and those with renal or hepatic impairment, no specific dose adjustment is necessary as L-methylfolate is a naturally occurring nutrient.

Recent Clinical Evidence

Research evidence / Overview of studies for Deplin

Evidence for Adjunctive Use in Major Depressive Disorder (MDD)

Deplin (L-methylfolate) was studied for use as an additional treatment for adults experiencing Major Depressive Disorder, especially when they had an incomplete response to standard antidepressant therapy. The research primarily consisted of short-term, placebo-controlled clinical trials (RCTs), supplemented by pooled analyses and systematic reviews. These studies were used in research exploring how outcomes related to physical discomfort and daily functioning change over time. Researchers monitored changes in scores from standard symptom severity scales to track how symptoms evolved in the observed populations over the study period.

The studies monitored and reported changes in measured depression symptom scores in the observed populations, with one group receiving adjunct L-methylfolate and the other receiving placebo. Research examined how symptoms evolved toward predefined goals for improvement or a state of minimal symptoms (remission) in the observed populations during the short-term follow-up duration.

Evidence Related to Nutritional Requirements in Schizophrenia

The research foundation for L-methylfolate in the context of schizophrenia is significantly more preliminary. Studies explored the use of L-methylfolate in patients already stable on antipsychotic medication, focusing on individuals with specific genetic factors related to how their bodies process folate. The research was relevant in trials assessing short-term or episodic symptom patterns, particularly the negative symptoms (such as social withdrawal or reduced motivation) that are marked by functional limitations.

Initial small trials evaluated changes in Negative symptom scores in patients carrying a specific MTHFR genetic variant. Studies monitored both psychiatric symptoms and changes in blood levels of methylfolate. These initial research observations suggest that L-methylfolate may contribute to understanding symptom patterns, but the data are still emerging.

Research Gaps and What Remains Uncertain

The existing research provides insight into short-term changes, but several limitations prevent broad conclusions. The sample sizes were modest in the pivotal MDD trials, and the evidence quality varies across studies. Long-term effects are not fully established for either MDD or schizophrenia, and data are still emerging, particularly regarding how L-methylfolate affects functional limitations and daily functioning over time.

Key Studies & References

  1. L-Methylfolate in Antidepressant Non-responders: The Impact of Body Weight and Inflammation (Post-hoc analysis)
  2. L-METHYLFOLATE CALCIUM Tablets 7.5mg Dietary Ingredients (FDA / DailyMed Label)

Frequently Asked Questions (FAQ)

Common questions about Deplin (FAQ)

Q: What is the main difference between Deplin and a standard B vitamin supplement?

Deplin is uniquely classified by the U.S. Food and Drug Administration (FDA) as a Prescription Medical Food. This designation sets it apart from general dietary or B vitamin supplements, as it is specifically formulated for the clinical dietary management of established nutritional requirements linked to a specific condition. Official sources indicate it is intended for use only under the supervision of a physician.

Q: How long does it usually take to notice the potential effects of Deplin?

Official clinical studies indicated that some individuals observed effects within 30 days when Deplin was used alongside an antidepressant medication. As with any medication, individual responses to treatment can vary.

Q: Can Deplin be taken long-term?

The official product information addresses the topic of prolonged therapy. It includes a specific warning that continuous use may be associated with a decrease in Vitamin B12 serum levels. Monitoring of B12 levels by a healthcare provider is noted as necessary for prolonged use, and the product's use is indicated under the supervision of a physician.

Q: Are there any common supplements that should be avoided while taking Deplin?

The product labeling states that all prescription and non-prescription medications, vitamins, and herbal products should be reviewed with a healthcare professional before use. This review is intended to ensure that any potential effect on folate levels or drug plasma levels is considered.

Q: Why do doctors recommend Deplin for some people with low folate levels?

The product provides L-methylfolate, which official documents describe as the biologically active form of folate. This form can be directly used by the body to address nutritional requirements related to folate deficiency, bypassing the conversion steps required by folic acid.

Q: What is the difference between L-methylfolate and folic acid?

L-methylfolate is the active form of folate found in the body, whereas folic acid is a synthetic precursor. Official product information notes that L-methylfolate can be utilized directly without the need for the enzymatic conversion that folic acid requires. This makes L-methylfolate the bioavailable component necessary for certain metabolic pathways.

Q: Does Deplin have to be taken at a specific time of day?

The administration guidelines specify that the product is taken once daily. Official instructions also state that it may be taken with or without food. No specific time of day (morning or evening) is mandated in the official documents.

Q: Can I take Deplin if I have an MTHFR gene variation?

Official clinical research has explored the use of L-methylfolate in patients who have certain genetic variations affecting how their bodies process folate. L-methylfolate is studied in this context because it is the active form that bypasses some of the related enzymatic conversion steps.

Q: Are the side effects of Deplin generally mild?

The official labeling does not use the word 'mild' to describe the adverse reaction profile. It notes that the most frequently reported adverse reactions affect the nervous system and the gastrointestinal system. These may include nausea, flatulence, irritability, altered sleep patterns, and difficulty concentrating.

Q: Why might a person's body have trouble processing folic acid?

Folic acid is a precursor that requires an enzymatic conversion process within the body to be turned into the active form, L-methylfolate. This conversion process is described in official documentation as potentially being less efficient or impaired in certain individuals.

Q: Can taking Deplin affect the results of other blood tests?

Official safety warnings state that large doses of folate can mask the blood-related symptoms (hematology) of pernicious anemia. This masking effect can complicate the diagnosis of a Vitamin B12 deficiency.

Q: Are there any foods or drinks that should be avoided when taking Deplin?

Deplin is designed to be taken with or without food. While official labeling does not specify any particular food restrictions, general medical guidance notes that excessive alcohol consumption can be a lifestyle factor that may impact folate levels.

Q: How does Deplin relate to the management of low folate levels?

Deplin is indicated as a medical food for the dietary management of low plasma or low red blood cell folate in individuals with an established medical condition. Its purpose is to provide the active, usable form of this essential nutrient.

Q: Are headaches a commonly reported side effect of Deplin?

According to the official governmental regulatory documents, headache is not listed among the most frequently reported documented adverse reactions for Deplin.

Q: Does Deplin contain any common allergens like gluten or lactose?

Official labeling states that use is strictly contraindicated in patients with a known history of hypersensitivity or allergic reactions to any component of the product. Official instructions state that the full ingredient list should be reviewed with a healthcare provider, as specific excipients like gluten or lactose are not always listed in regulatory summaries.

Q: What are the general expectations for a follow-up appointment after starting Deplin?

Official product precautions indicate that blood work checks may be performed during the course of therapy. This monitoring is generally conducted to track treatment status and ensure safety, particularly in relation to Vitamin B12 levels.

Q: Can men take Deplin?

Yes, official safety information and clinical studies for the product indicate that it is intended for use in adults who are managing specific nutritional requirements. The labeling contains no specific gender restrictions.

Q: Does Deplin interact with alcohol?

The official product labeling does not list a direct interaction between Deplin and alcohol. However, official precautions note that excessive alcohol consumption is a general lifestyle factor that may influence overall folate levels in the body.

Q: If I miss a dose of Deplin, what am I supposed to do?

Regulatory patient information contains specific guidance for managing a missed dose, including when to take a remembered dose and when to skip it. This guidance specifies not to double the dose. Clarification on individual administration schedules is obtained from a healthcare provider.

Q: Are there any known long-term safety concerns associated with Deplin?

The official warnings address two main safety concerns. First, prolonged therapy may be associated with a potential decrease in Vitamin B12 serum levels. Second, Deplin is restricted from being used as the sole treatment when a Vitamin B12 deficiency is already present.

Q: Is Deplin a mood stabilizer?

Official pharmacological classifications describe Deplin as a Folate Analog and a Tri-monoamine Modulator (TMM) due to its role in regulating brain chemistry. It is not classified as a traditional mood stabilizer or an antidepressant medication.

Q: What is the purpose of the different strengths of Deplin (e.g., 7.5 mg vs 15 mg)?

Official product information notes that the usual adult daily dose ranges from 7.5 mg to 15 mg. The selection between the available strengths is determined based on the patient's nutritional requirements under the supervision of a physician.

Q: Does Deplin have a warning about drowsiness or affecting driving ability?

The official list of documented adverse reactions does not specifically list drowsiness. However, reported side effects include difficulty concentrating, confusion, and impaired judgment, which are noted as being effects that may impact a person's ability to perform complex tasks.

Q: What does 'adjunctive' mean in the context of taking Deplin with antidepressants?

Adjunctive is a term used in official indications to describe how Deplin is intended to be used. It means the product is an additional treatment that is used alongside and designed to enhance the effects of another prescribed medication, such as an antidepressant.

How should Deplin be stored and disposed of?

How to Store and Dispose of Deplin?

The storage and disposal instructions for Deplin (L-methylfolate) are strictly defined in official regulatory documents to maintain its stability and ensure safe handling.

Storage Requirements

Deplin must be stored at Controlled Room Temperature, typically defined as 15 C to 30 C (59 F to 86 F). The product must be protected from heat, light, and moisture; therefore, it should be kept in a dry place, such as avoiding storage in a bathroom. The medication must remain in its original container and be kept tightly closed when not in use. As a mandatory safety measure, Deplin must be stored out of the reach and sight of children and pets.

Disposal Requirements

Unused or expired Deplin should be discarded through a drug take-back program. Regulatory guidance specifies not to flush this medication down the toilet or pour it down a drain. If a take-back program is unavailable, official instructions permit mixing the product with an undesirable substance and placing it in a sealed bag before disposal in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Deplin found in:

A-Z Index: